Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02065882 |
|
Recruitment Status :
Completed
First Posted : February 19, 2014
Last Update Posted : July 27, 2022
|
Sponsor:
Biotest
Collaborators:
ICON plc
SYNLAB Analytics and Services Germany GmbH
Phoenix Clinical Research
Accovion GmbH
Pharmetheus AB
Information provided by (Responsible Party):
Biotest
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 18, 2020 |
| Actual Study Completion Date : | November 18, 2020 |